A Randomized, Single-blind Phase II Study Evaluating the Efficacy, Safety and Pharmacokinetics of Remimazolam in General Anaesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the PACU/ICU

Trial Profile

A Randomized, Single-blind Phase II Study Evaluating the Efficacy, Safety and Pharmacokinetics of Remimazolam in General Anaesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follow-up Sedation in the PACU/ICU

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Remimazolam (Primary) ; Propofol; Sevoflurane
  • Indications Anaesthesia; Sedation
  • Focus Therapeutic Use
  • Sponsors PAION
  • Most Recent Events

    • 01 Oct 2014 Results published in PAION media release and presented at the Anesthesiology 2014 Annual Meeting, according to the media release.
    • 01 Oct 2014 Primary endpoint (successful anaesthesia, not requiring sedative rescue therapy) has been met, according to a PAION media release.
    • 11 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top